Nicholas Hoffman & Company’s Zimmer Biomet ZBH Stock Holding History

Nicholas Hoffman & Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Sell	15,143 -291	-2%	-$25.5K	0.03%	127
2026 Q1	$1.4M	Buy	15,434 +2,223	+17%	+$204K	0.03%	109
2025 Q4	$1.19M	Buy	13,211 +11	+0.1%	+$1.04K	0.03%	126
2025 Q3	$1.3M	Sell	13,200 -1,955	-13%	-$194K	0.03%	109
2025 Q2	$1.38M	Buy	15,155 +5,294	+54%	+$512K	0.04%	104
2025 Q1	$1.12M	Buy	9,861 +17	+0.2%	+$1.82K	0.04%	115
2024 Q4	$1.04M	Hold	9,844	–	–	0.04%	117
2024 Q3	$1.06M	Buy	+9,844	New	+$1.07M	0.04%	120

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nicholas Hoffman & Company's ZBH Position: Q2 2026 in Review

Nicholas Hoffman & Company reduced its Zimmer Biomet (ZBH) stake by 1.9% in Q2 2026, selling an estimated $25.5K and leaving 15,143 shares worth $1.3M. The position accounts for 0.03% of the portfolio, ranked #127.

Nicholas Hoffman & Company first reported a position in ZBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.4M in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Nicholas Hoffman & Company held 15,143 shares of Zimmer Biomet worth $1.3M as of Q2 2026.
Nicholas Hoffman & Company sold 291 Zimmer Biomet shares in Q2 2026, an estimated $25.5K.
Zimmer Biomet made up 0.03% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #127 holding.
Nicholas Hoffman & Company first reported a position in Zimmer Biomet in Q3 2024 and has held it in 8 quarters since.
Nicholas Hoffman & Company's Zimmer Biomet position peaked at $1.4M in Q1 2026.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.